AHR and breast cancer: We recently reported that GEN prevents BRCA1 hypermethylation in ERα-positive MCF7 BC cells treated with the AHR agonist TCDD, and reverses constitutive BRCA1 CpG methylation in ERα-negative HER2-enriched cells with constitutive high levels of AHR [42].